Sage Group (OTCMKTS:SGPYY – Get Free Report) was downgraded by equities researchers at Canaccord Genuity Group from a “strong-buy” rating to a “hold” rating in a research report issued on Monday, Zacks reports.
A number of other equities research analysts also recently issued reports on the company. Citigroup reissued a “buy” rating on shares of Sage Group in a research report on Thursday, July 30th. Morgan Stanley restated an “overweight” rating on shares of Sage Group in a research note on Friday, August 21st. Investec raised Sage Group to a “buy” rating in a report on Friday, October 9th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Sage Group in a research report on Thursday, July 30th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of Sage Group in a research report on Wednesday, July 29th. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Sage Group presently has a consensus rating of “Moderate Buy”.
Get Our Latest Analysis on SGPYY
Sage Group Stock Down 3.2%
Shares of SGPYY opened at $61.89 on Monday. Sage Group has a 12 month low of $41.80 and a 12 month high of $64.55. The firm’s 50 day moving average is $56.51 and its 200-day moving average is $49.99.
About Sage Group
The Sage Group plc is a United Kingdom-based technology company that develops business-management software and services for small and medium-sized businesses. Its solutions are designed to help organizations manage accounting, finance, payroll, human resources, enterprise operations and related administrative processes.
Sage’s product portfolio includes cloud-based accounting and financial-management applications, payroll and human-resources tools, enterprise-management software, and payment-related services.
Featured Articles
- Five stocks we like better than Sage Group
- Verizon’s Q3 Results Show Why SpaceX’s Spectrum Grab Isn’t a Major Threat
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
Receive News & Ratings for Sage Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sage Group and related companies with MarketBeat.com's FREE daily email newsletter.
